Business
9amHealth to Expand Access to Obesity Management Treatment through New Employer Health Benefits Offering
9amHealth, a leader in virtual cardiometabolic care, today announced a new offering designed to make access to obesity management medications and care more sustainable for employers. The "No-Barriers Bundle" offers access to FDA-approved obesity medicines from Eli Lilly and Company (Lilly) and Novo Nordisk, along with 9amHealth's comprehensive cardiometabolic care program, creating a transparent, cost-efficient pathway for employers to support their teams' health.
About this update from Eli Lilly And Company
[{"type":"text","content":"The new "No-Barriers Bundle" helps employers enable access to FDA-approved obesity management medications and care through a transparent, outcomes-driven model integrated with 9amHealth's cardiometabolic care platform.","length":232,"tagName":"p"},{"type":"text","content":"SAN DIEGO, Nov. 21, 2025 /PRNewswire/ -- 9amHealth, a leader in virtual cardiometabolic care, today announced a new offering designed to make access to obesity management medications and care more sustainable for employers. The "No-Barriers Bundle" offers access to FDA-approved obesity medicines from Eli Lilly and Company (Lilly) and Novo Nordisk, along with 9amHealth's comprehensive cardiometabolic care program, creating a transparent, cost-efficient pathway for employers to support their teams' health.","length":527,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/9am.health Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/9am.health Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/0ff63062325cfc78d093cd96f33bfe41"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FSyK2_2sV7TGyre7sglACg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/0ff63062325cfc78d093cd96f33bfe41","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/1628937/9amhealth_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Currently, just over half of large employers cover GLP-1 medications. Through the launch of this new offering, 9amHealth will provide a clear and predictable model that brings transparency to medication and total care costs, including access to both Novo Nordisk and Lilly products for patients with a valid, on-label prescription. Employers gain the confidence to extend coverage responsibly—supported by clinical oversight, integrated data, and a care model focused on safety, outcomes, and affordability.","length":512,"tagName":"p"},{"type":"text","content":""Employers want to do the right thing for their people—but rising healthcare costs and complexity have made obesity care coverage difficult to manage," said Paul Geevarghese, Co-Founder and Chief Operating Officer at 9amHealth. "We built these solutions to give employers transpar...